The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study

被引:19
|
作者
Melchior, T [1 ]
Rask-Madsen, C
Torp-Pedersen, C
Hildebrandt, P
Kober, L
Jensen, G
机构
[1] Hillerod Univ Hosp, Dept Cardiol, DK-3400 Hillerod, Denmark
[2] Glostrup Univ Hosp, Dept Cardiol, DK-2600 Glostrup, Denmark
[3] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Copenhagen, Denmark
[4] Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Frederiksberg, Denmark
关键词
diabetes mellitus; heart failure; myocardial infarction; mortality; prognosis;
D O I
10.1016/S1388-9842(00)00117-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Information about the occurrence of heart failure in the acute phase of myocardial infarction (MI) in diabetic patients and its impact on prognosis are sparse. Aim: The purpose of the present study was to describe how MI patients with diabetes mellitus (DM) differed from MI patients without DM with respect to the occurrence of heart failure and with respect to the influence of heart failure on mortality during follow-up 30 days extending to 15 years. Methods: The study is a retrospective long-term follow-up of prospectively recorded data concerning 1954 consecutive cases of MI admitted to one coronary care unit (CCU) between 1979 and 1983, DM was diagnosed in 10% (n = 194), with 17% (n = 33) on insulin therapy. Patients with DM comprised of a higher proportion of women (DM 36% vs. no DM 26%, P < 0.001) compared with non-diabetic patients. Baseline risk factors were more prevalent in the patients with DM. The cumulative incidence of heart failure was higher among patients with than without DM (DM 54% vs. no DM 34%, P < 0.001), The incidence of life-threatening arrhythmias were similar in both groups. Only 2% of patients with DM and heart failure survived 10 years of follow-up compared with 15% of the non-diabetic patients with heart failure (P < 0.001). In multivariate analysis DM was not independently associated with 30 days mortality. During long-term follow-up DM was an important risk factor for mortality independent on the presence of heart failure. Conclusion: DM disposes to the development of heart failure. In acute myocardial infarction diabetic patients with heart failure have a worse prognosis than non-diabetic patients with heart failure. (C) 2001 European Society of Cardiology. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [21] PROGNOSIS AFTER PORTACAVAL ANASTOMOSIS - 15-YEAR FOLLOW-UP
    WINDLE, R
    PEACOCK, JH
    BRITISH JOURNAL OF SURGERY, 1975, 62 (09) : 701 - 706
  • [22] Non-diabetic glycosuria - A follow-up study with glucose tolerance tests
    Dewees, EJ
    Langner, PH
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1942, 204 (04): : 491 - 495
  • [23] 16-Year Mortality in Diabetic Patients with Macrovascular Disease as Compared to Non-Diabetic Patients with Myocardial Infarction
    Londahl, Magnus
    Nilsson, Anders L.
    Katzman, Per
    DIABETES, 2014, 63 : A633 - A634
  • [24] Results of coronary angioplasty in diabetic and non diabetic patients.: A one year follow-up study
    Dussaillant, G
    Pacheco, C
    Ramírez, A
    Ugalde, H
    Antibilo, S
    Silva, AM
    Farías, E
    Oyonarte, M
    REVISTA MEDICA DE CHILE, 2001, 129 (08) : 861 - 870
  • [25] The impact of residual non-culprit stenoses in diabetic and non-diabetic patients with ST elevation myocardial infarction
    Burgess, S. N.
    Juergens, C. P.
    Nguyen, T. L.
    Leung, M.
    Richards, D. A. B.
    Thomas, L.
    Mussap, C. J.
    Lo, S. T. H.
    French, J. K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 324 - 324
  • [26] Clinical predictors and microalbuminuria in non-diabetic patients with acute myocardial infarction: Results of three year follow up on global mortality.
    Berton, GS
    Cordiano, R
    Palmieri, R
    Guarnieri, GL
    Buttazzi, P
    Stefani, M
    Gheno, G
    De Toni, R
    Mormino, P
    Palatini, P
    CIRCULATION, 2001, 104 (17) : 379 - 379
  • [27] Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects:: A 10-year follow-up study
    Voutilainen-Kaunisto, R
    Teräsvirta, M
    Uusitupa, M
    Niskanen, L
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2001, 79 (02): : 163 - 168
  • [28] SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart
    Lim, V. G.
    Bell, R. M.
    Arjun, S.
    Kolatsi-Joannou, M.
    Long, D. A.
    Yellon, D. M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 120 : 27 - 27
  • [29] The effect of buicindolol in diabetic and non-diabetic patients with advanced heart failure
    Domanski, M
    Krause-Steinrauf, H
    Deedwania, P
    Ghali, J
    Gilbert, EM
    Katz, RJ
    Lindenfeld, J
    Lowes, B
    Martin, W
    McGrew, F
    Bristow, M
    CIRCULATION, 2001, 104 (17) : 754 - 754
  • [30] Silent myocardial ischemia prognosis: A six-year follow-up of 203 diabetic patients.
    Sejil, SS
    Janand-Delenne, BS
    Avieri-Nos, JF
    Habib, GS
    Labastie, NS
    Vague, PA
    Lassmann-Vague, VJ
    DIABETES, 2004, 53 : A171 - A171